Effect of Photobiostimulation Versus Pulsed Electromagnetic Field on Quality of Life in Adults With Chronic Rhinosinusitis
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: pulsed electromagnetic therapy, Photobiostimulation, Self-sinus massage technique.
- Who it may be relevant to
- Registry conditions: Photobiostimulation, Pulsed Electromagnetic Filed, Low Level Laser Therapy, Chronic Rhinosinusitis (Diagnosis). Basic parameters: 20 years — 40 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This study was done to find out the effect of photobiostimulation and pulsed electromagnetic field in patients with chronic rhinosinusitis on: * Quality of life. * Pulmonary function. * Mean platelet volume. * headache . * total nasal symptoms.
Detailed description
Chronic rhinosinusitis is a severe disease that significantly impacts a patient's quality of life, leading to significant economic impacts on healthcare resources and absenteeism. Symptoms interfere with daily activities and can lead to medication resistance. Treatment options like steroids, oral antibiotics, and sinus surgery are less effective, and disease recurrence remains high even after surgery. Alternative therapies like low-level laser therapy and pulsed electromagnetic filed have shown promise in improving symptoms and potentially making low-level laser therapy a non-invasive treatment for Chronic rhinosinusitis
Interventions
- Device pulsed electromagnetic therapy
We will use the ASTAR Physio MG 827, a generator and 75 cm solenoid couch, in a pulsed electromagnetic field group. Participants will be placed comfortably in the solenoid, and the device will be turned on and programmed for 20 guesses for 10 minutes, 7 Hz, three times per week for 8 weeks. - Device Photobiostimulation
The therapy will be performed using an ASTAR PhysioGo -As low level laser therapy device with a wavelength of 830 nm, 30 mW power output, and 1 J energy dose. Patients will be supine and wear laser safety goggles. The laser will be applied to six locations over the maxillary or frontal sinuses, administered in a continuous manner for 33 seconds per spot, totaling 198 seconds and 6 J per session - Other Self-sinus massage technique
Participants are instructed to perform self-massage to their frontal and maxillary sinuses at home twice daily, in the morning and evening. For the frontal sinus, place the fingers above the eyebrows on either side of the forehead, and gently circular outward massage for three sets of 30 seconds, repeated twice a day.
Primary outcome measures
- assessment of change of quality of life [Time frame: at baseline and after 8 weeks]
Secondary outcome measures (5)
- assessment of change of pulmonary functions [Time frame: at baseline and after 8 weeks]
- assessment of change of Mean platelet volume [Time frame: at baseline and after 8 weeks]
- assessment of change of white blood cells count [Time frame: at baseline and after 8 weeks]
- assessment of change of headache pain severity [Time frame: at baseline and after 8 weeks]
- assessment of change of total nasal symptoms [Time frame: at baseline and after 8 weeks]
Eligibility criteria
Inclusion criteria
- Participants suffering from mild to moderate symptoms (baseline Total nasal symptoms score ≤ 9).
- Subjects age range from 20 to 40 years old.
- Patients of both sexes.
- proven positive allergy test (skin prick test or multiple allergen simultaneous test) to any of the common perennial allergens such as dust mites, molds, insects, and animal dander within the last 12 months
Exclusion criteria
- Pregnant or breastfeeding women.
- Patients with a definite deviated nasal septum, or history of operation within the last 6 months.
- Hypertension, diabetes mellitus, malignancy, active pulmonary tuberculosis, active respiratory disease like asthma, or other systemic diseases.
- Long-term use of corticosteroids or immunosuppressive agents.
- Participation in another clinical study within 30 days.
- Hyperthyroidism
- Patients who had used antihistamines within 1 week, topical corticosteroids within 2 weeks, systemic corticosteroids within 4 weeks, anticholinergic drugs within 3 days, antileukotriene drugs within 1 week, decongestants within 3 days, tricyclic antidepressants or phenothiazines within 2 weeks, nonsteroidal analgesics within 2 weeks, and other drugs that the researchers believed were inappropriate.
- Patients with Tattoos, moles and dark skin
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
Egypt · 1 center
- out-patient clinic, faculty of physical therapy, October University for Modern Sciences an — Cairo
Identifiers
NCT: NCT06986629 · Samar-005562